Multi‐Omic Profiling Reveals Immune Cell Priming Signature Linked to Lupus Prognosis

Journal:

Arthritis & Rheumatology

Published:

2026-02-24

DOI:

10.1002/art.70105

Affiliations:

6

Authors:

24

Go to article

Institutions	Authors	Share
AstraZeneca United States, United States of America (USA)	16.000000 16.000000	0.67
NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), United States of America (USA)	7.000000	0.29
AstraZeneca, United Kingdom (UK)	1.000000	0.04

Interested in Clinical Sciences?